Baird upgrades Pool Corp to Outperform, citing cyclical recovery and resilient discretionary spending in the pool and outdoor living sector, with a price target of $320.
Industrial distributor Applied Industrial Technologies (AIT) reported a 8.4% revenue jump in its fiscal Q2, though higher costs and demand volatility prompted a key analyst to trim its price target while maintaining a positive long-term outlook.
As consumer sentiment sours, investors are pivoting to sectors like financial technology and home construction, anticipating policy moves from Washington aimed at easing cost-of-living pressures before the November elections.
Despite plunging to multi-year lows, Litecoin is seeing sustained demand from payment gateways, privacy features, and long-term accumulation, suggesting a potential foundation for recovery amid a brutal market.
A landmark $100 million in tokenized real-world assets on the XDC Network, led by fintech Liqi, signals Brazil's shift from blockchain pilots to institutional-scale adoption, outpacing many developed economies.
Despite processing over $8.4 trillion in January—dwarfing traditional card networks—Circle's share price continues its steep decline, highlighting a stark divide between booming on-chain utility and skeptical market valuation.
Despite robust revenue growth in 2025, Meta Platforms' stock underperformed the market. With a strategic pivot towards high-return AI investments and new advertising frontiers, analysts see the social media giant as attractively valued for a potential comeback this year.
Harvard Bioscience announces the closure of its Holliston, MA manufacturing facility, shifting operations to Minneapolis and Europe by 2027. The move, part of a strategic consolidation, is projected to yield $4 million in annual savings but raises concerns over local job losses and the state's business climate.
The Gulf Coast regional bank announces a dividend increase, with analysts highlighting its sustainable payout ratio and earnings growth trajectory as key indicators of robust financial health.
A new discounted cash flow analysis suggests Select Water Solutions' stock is trading at a significant discount to its estimated intrinsic value, with potential political tailwinds from the upcoming election adding to the investment thesis.
The Trump administration launches a major public-private initiative to stockpile essential minerals, aiming to shield U.S. manufacturers from supply shocks and reduce strategic dependence on China.
The merger, set to create a premier gold-copper producer, targets significant production growth by 2026 and will maintain its headquarters in Vancouver under the Eldorado banner.
Tesla's full-year 2025 results show a sharp 46% decline in net income, marking a second consecutive year of falling profits as EV competition intensifies and the company accelerates its shift toward AI and robotics.
Despite revenue meeting expectations, General Dynamics' stock fell nearly 5% after its annual report, with analysts slightly lowering EPS forecasts and flagging a projected growth slowdown against industry peers.
Morgan Stanley has increased its price target for Edison International (EIX) to $61, citing the utility's progress on debt reduction and wildfire cost securitization, even as it maintains a cautious Underweight rating. The move comes alongside a broader reassessment of the North American utilities sector.
Himax Technologies' stock has declined 9% over the past quarter, prompting a closer look at its underlying financial health. A low Return on Equity and high dividend payout ratio raise questions about its growth trajectory in a competitive semiconductor landscape.
Wolfe Research upgrades Target (TGT) to 'Peer Perform,' citing an improved risk-reward balance as operational progress offsets a lowered earnings outlook. DA Davidson also raises its price target, highlighting margin recovery potential.
Analysts at Leerink Partners have raised their price target for Bristol-Myers Squibb (BMY), highlighting a series of pivotal clinical trial results expected in 2025. The firm sees significant upside potential as the market currently undervalues the company's robust pipeline, despite near-term earnings adjustments.
Bank of America has upgraded Comcast (CMCSA) to 'Buy' and raised its price target to $37, citing the media giant's strategic reorganization and potential to shed a long-standing 'conglomerate discount' as it prepares NBCUniversal for new partnerships or a sale.
Goldman Sachs maintains a Neutral stance on Pfizer (PFE) with a $26 price target, as the pharmaceutical giant navigates significant margin pressures from looming patent expiries and a constrained business development budget.
